Committee for Orphan Medicinal Products (COMP): 6-8 October 2026

The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.

Date

- ,

Location

European Medicines Agency, Amsterdam, the Netherlands

Documents

Share this page